NDC 47781-407-04
buprenorphine transdermal system 10 ug/h
buprenorphine · PATCH, EXTENDED RELEASE
buprenorphine transdermal system is a patch, extended release containing buprenorphine at a strength of 10 ug/h. Manufactured by Alvogen Inc..
Key Facts
- Brand Name
- buprenorphine transdermal system
- Generic Name
- buprenorphine
- NDC Code (Package)
47781-407-04- NDC Code (Product)
47781-407- Manufacturer
- Alvogen Inc.
- Strength
- 10 ug/h
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- DEA Schedule
- Schedule III (Controlled)
- Application #
- ANDA207490
- Drug Class
- Partial Opioid Agonist [EPC]
- Marketing Start
- 05/17/2022
Recall History
No Recall HistoryView Full Drug Page
buprenorphine transdermal system — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.